↓ Skip to main content

Made in Europe: will artemisinin resistance emerge in French Guiana?

Overview of attention for article published in Malaria Journal, May 2013
Altmetric Badge

Mentioned by

twitter
1 X user

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
42 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Made in Europe: will artemisinin resistance emerge in French Guiana?
Published in
Malaria Journal, May 2013
DOI 10.1186/1475-2875-12-152
Pubmed ID
Authors

Mathieu Nacher, Philippe J Guérin, Magalie Demar-Pierre, Félix Djossou, François Nosten, Bernard Carme

Abstract

Resistance to artemisinin casts a shadow on the fight against malaria. The importance of illegal gold miners and of malaria in isolated regions of French Guiana constitutes a threat that endangers the fight against malaria in the Amazon. The hurdles of French laws and the remoteness of the territory from France make it impossible for the system to adapt to the problem of total inaccessibility of an important part of the malaria problem. Transmission is high in these areas and gold miners self-medicate with erratic regimens of artemisinin combinations, thus creating perfect conditions for the emergence of resistance. What needs to be done is being done, but within the limits of national law, with some results. However, facing the same difficult problem, Suriname shows more flexibility and is doing much better than French Guiana despite having lower resources. Local authorities in French Guiana cannot overrule the laws that block appropriate malaria care from reaching a third of malaria-exposed persons. Thus the health authorities in France should take immediate calibrated legislative and financial measures to avoid a predictable disaster.

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 42 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 3 7%
Unknown 39 93%

Demographic breakdown

Readers by professional status Count As %
Student > Master 7 17%
Researcher 5 12%
Other 4 10%
Student > Doctoral Student 4 10%
Student > Postgraduate 4 10%
Other 14 33%
Unknown 4 10%
Readers by discipline Count As %
Medicine and Dentistry 17 40%
Agricultural and Biological Sciences 6 14%
Economics, Econometrics and Finance 2 5%
Social Sciences 2 5%
Environmental Science 2 5%
Other 7 17%
Unknown 6 14%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 07 May 2013.
All research outputs
#19,854,550
of 24,400,706 outputs
Outputs from Malaria Journal
#5,309
of 5,827 outputs
Outputs of similar age
#148,615
of 196,060 outputs
Outputs of similar age from Malaria Journal
#66
of 74 outputs
Altmetric has tracked 24,400,706 research outputs across all sources so far. This one is in the 10th percentile – i.e., 10% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,827 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.0. This one is in the 4th percentile – i.e., 4% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 196,060 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 74 others from the same source and published within six weeks on either side of this one. This one is in the 1st percentile – i.e., 1% of its contemporaries scored the same or lower than it.